These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9595655)

  • 1. Routine screening of blood donations for HCV RNA.
    Araújo FM; Koch MC; Henriques I; Monteiro F; Araújo AR; Cunha-Ribeiro LM
    Vox Sang; 1998; 74(3):211. PubMed ID: 9595655
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.
    Lee SR; Peterson J; Niven P; Bahl C; Page E; DeLeys R; Giordano-Schmidt D; Baggett D; Green G
    Vox Sang; 2001 Jan; 80(1):19-23. PubMed ID: 11339063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
    Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
    Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus RNA positivity among RIBA-3 indeterminates.
    Jha J; Arankalle VA; Banerjee K
    Vox Sang; 1995; 69(2):145-6. PubMed ID: 8585200
    [No Abstract]   [Full Text] [Related]  

  • 6. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
    Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
    Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Kasahara A; Fusamoto H; Ohtani S; Okubo Y; Kamada T
    Vox Sang; 1994; 67(3):280-5. PubMed ID: 7532341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.
    Seed CR; Cheng A; Ismay SL; Bolton WV; Kiely P; Cobain TJ; Keller AJ;
    Transfusion; 2002 Oct; 42(10):1365-72. PubMed ID: 12423522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus blood donor screening: recombinant immunoblot assay interpretation re-examined.
    Perrons CJ; Garson JA
    Vox Sang; 1993; 64(4):253. PubMed ID: 7685973
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
    Bååth L; Widell A
    Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
    [No Abstract]   [Full Text] [Related]  

  • 13. [HCV RNA assessment by PCR technique for screening post-transfusion HCV infection among blood donors].
    Xing W; Xu H; Ma R; Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):211-2. PubMed ID: 12113682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 16. Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective.
    Loubière S; Rotily M; Durand-Zaleski I; Costagliola D
    Vox Sang; 2001 May; 80(4):199-204. PubMed ID: 11438026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of hepatitis C virus RNA in the serum by the Amplicor HCV PCR kit.
    Prati D; Capelli C; Bosoni P; Mozzi F; Zanella A; Sirchia G
    Vox Sang; 1994; 67(1):112-4. PubMed ID: 7975444
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-GOR to screen HCV-RNA-positive blood donors.
    Watanabe J; Matumoto C; Nishioka K; Yoshizawa H
    Lancet; 1991 Aug; 338(8763):391. PubMed ID: 1677735
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.